ArticleFrontiers in medicine2025
OculusNet: Detection of retinal diseases using a tailored web-deployed neural network and saliency maps for explainable AI.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The evolving role of artificial intelligence in optimizing treatment and patient selection in diabetic macular edema.Indian journal of ophthalmology · 2026Review
- Efficient and explainable histopathology for cancer detection using dual-teacher distillation and integrated gradients.Frontiers in medicine · 2026Article
- PAIR: Evaluating the Limits of Agreement Among Non-Retinal Specialist Using PathFinder Artificial Intelligence Tool for Retinal Disease Referrals: A Prospective Observational Study.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Retinal diseases are among the leading causes of blindness worldwide, requiring early detection for effective treatment. Manual interpretation of ophthalmic imaging, such as optical coherence tomography (OCT), is traditionally time-consuming, prone to inconsistencies, and requires specialized expertise in ophthalmology. This study introduces OculusNet, an efficient and explainable deep learning (DL) approach for detecting retinal diseases using OCT images. The proposed method is specifically tailored for complex medical image patterns in OCTs to identify retinal disorders, such as choroidal neovascularization (CNV), diabetic macular edema (DME), and age-related macular degeneration characterized by drusen. The model benefits from Saliency Map visualization, an Explainable AI (XAI) technique, to interpret and explain how it reaches conclusions when identifying retinal disorders. Furthermore, the proposed model is deployed on a web page, allowing users to upload retinal OCT images and receive instant detection results. This deployment demonstrates significant potential for integration into ophthalmic departments, enhancing diagnostic accuracy and efficiency. In addition, to ensure an equitable comparison, a transfer learning approach has been applied to four pre-trained models: VGG19, MobileNetV2, VGG16, and DenseNet-121. Extensive evaluation reveals that the proposed OculusNet model achieves a test accuracy of 95.48% and a validation accuracy of 98.59%, outperforming all other models in comparison. Moreover, to assess the proposed model's reliability and generalizability, the Matthews Correlation Coefficient and Cohen's Kappa Coefficient have been computed, validating that the model can be applied in practical clinical settings to unseen data.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.